Attovia Therapeutics, Inc. (ATTO) has 16 SEC Form 4 insider filings on record in the last 90 days. That includes 8 insider purchases totalling $86.4M. Most recent filing: Aug. 28, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 28, 2026 filed Aug. 5, 2026 | WALSH COLIN Director | +$10,281,416 | 25,859,351 | — | No | |
|
|
||||||
| Aug. 28, 2026 filed Aug. 5, 2026 | GOLDMAN SACHS GROUP INC Insider | +$10,281,416 | 25,859,351 | — | No | |
|
|
||||||
| Aug. 13, 2026 filed Aug. 5, 2026 | WALSH COLIN Director | +$8,033,342 | 25,753,544 | — | No | |
|
|
||||||
| Aug. 13, 2026 filed Aug. 5, 2026 | GOLDMAN SACHS GROUP INC Insider | +$8,033,342 | 25,753,544 | — | No | |
|
|
||||||
| Aug. 10, 2026 filed Aug. 6, 2026 | Deep Track Biotechnology Master Fund, Ltd. 10% Owner | $0 | 20,138,956 | — | No | |
|
|
||||||
Showing the 5 most recent of 16 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free